Hasegawa N, Yamamoto M, Yamamoto K
Division of Cell Biology, Yakult Central Institute for Microbiological Research, Tokyo, Japan.
J Cell Physiol. 1988 Dec;137(3):603-7. doi: 10.1002/jcp.1041370331.
We characterized human umbilical vein (HUV) endothelial cells as to cell growth and prostacyclin production to get a better understanding of the properties of endothelial cells. Endothelial cell growth supplement (ECGS) and basic fibroblast growth factor (FGF) stimulated HUV endothelial cell growth. Heparin further enhanced the cell growth stimulated by ECGS, but not the cell growth stimulated by FGF or in the absence of these growth factors. In the presence of ECGS, the prostacyclin-producing capacity of the cells was inhibited by heparin. However, in the presence of FGF of in the absence of growth factors, heparin did not inhibit prostacyclin production. Therefore, it is likely that there is a specific correlation between heparin and growth factors for endothelial cells in the blood vessel to maintain nonthrombogenicity properly. Heparin-treated cultures may not be suitable for some examinations of prostacyclin production by vascular endothelial cells.
我们对人脐静脉(HUV)内皮细胞的细胞生长和前列环素生成进行了表征,以便更好地了解内皮细胞的特性。内皮细胞生长补充剂(ECGS)和碱性成纤维细胞生长因子(FGF)刺激HUV内皮细胞生长。肝素进一步增强了ECGS刺激的细胞生长,但不增强FGF刺激的细胞生长或在无这些生长因子情况下的细胞生长。在存在ECGS的情况下,肝素抑制细胞的前列环素生成能力。然而,在存在FGF或无生长因子的情况下,肝素不抑制前列环素生成。因此,肝素与血管内皮细胞生长因子之间可能存在特定关联,以适当维持非血栓形成性。肝素处理的培养物可能不适用于血管内皮细胞前列环素生成的某些检测。